
“‘The process of image analysis in clinical practice, not just in B.C. but worldwide, is primarily qualitative,’ says Dr. Rahmim, the project’s principal investigator and senior scientist at BC Cancer Research Institute (BCCRI). ‘A specialist must view the image and make an assessment of disease from what they see. Our intention is to develop new technologies using AI that can help better identify and evaluate tumours, with the ultimate aim of impacting care and outcomes for our patients.’
The group plans to publish their research and openly share the developed AI models online, to make them available for researchers and physicians worldwide. As part of the agreement, the anonymized data shared by BC Cancer, and the AI models and methods developed within the partnership, cannot be used for commercial purposes. The initial application of the models will be for clinical research trials, and the possibility of their use in clinical practice will be investigated.”
More on UBC scientists partner with Microsoft to develop next generation of cancer imaging and treatment tools via UBC Faculty of Medicine.